Optimizing Clinical Trials for Solid Tumors.
- Published in:
- Applied Clinical Trials, 2024, v. 33, n. 5, p. 20
- By:
- Publication type:
- Article
Works matching IS 10648542 AND DT 2024 AND VI 33 AND IP 5
Results: 9
1
2
AI Drives Industry Response to FDA’s Project Optimus.
- Published in:
- Applied Clinical Trials, 2024, v. 33, n. 5, p. 18
- By:
- Publication type:
- Article
3
Accelerating the Progress of Kinase Inhibitors in Oncology.
- Published in:
- Applied Clinical Trials, 2024, v. 33, n. 5, p. 16
- By:
- Publication type:
- Article
4
Where Innovation and Patients Meet to Improve Cancer Care.
- Published in:
- Applied Clinical Trials, 2024, v. 33, n. 5, p. 12
- By:
- Publication type:
- Article
5
PAVING THE WAY FOR AI’S POTENTIAL IN CLINICAL TRIALS.
- Published in:
- 2024
- By:
- Publication type:
- Interview
6
FAINT HOPES OF DISPELLING THE FOG AROUND CROSS-BORDER TRIALS IN EUROPE.
- Published in:
- Applied Clinical Trials, 2024, v. 33, n. 5, p. 9
- By:
- Publication type:
- Article
7
A FUN AND INSIGHTFUL EXPLORATION OF BEHAVIORAL SCIENCE.
- Published in:
- 2024
- By:
- Publication type:
- Interview
8
PROMISE AND PITFALLS: RETHINKING THE COMPLEX PROCESS FOR CANCER TRIALS.
- Published in:
- Applied Clinical Trials, 2024, v. 33, n. 5, p. 6
- By:
- Publication type:
- Article
9
A PROMISING FUTURE FOR ONCOLOGY R&D.
- Published in:
- Applied Clinical Trials, 2024, v. 33, n. 5, p. 3
- By:
- Publication type:
- Article